CALM3
- [1]. Clapham DE. Calcium signaling. Cell. 2007 Dec 14;131(6):1047-58. doi: 10.1016/j.cell.2007.11.028. PMID: 18083096. et al. Calcium signaling. Cell. 2007 Dec 14;131(6):1047-58. [Content Brief]
- [2]. Jensen HH, et al. Human Calmodulin Mutations. Front Mol Neurosci. 2018 Nov 13;11:396. [Content Brief]
- [3]. Gomez-Hurtado N, et al. Novel CPVT-Associated Calmodulin Mutation in CALM3 (CALM3-A103V) Activates Arrhythmogenic Ca Waves and Sparks. Circ Arrhythm Electrophysiol. 2016 Aug;9(8):10.1161/CIRCEP.116.004161 e004161. [Content Brief]
- [4]. Chaix MA, et al. Novel CALM3 mutations in pediatric long QT syndrome patients support a CALM3-specific calmodulinopathy. HeartRhythm Case Rep. 2016 Mar 16;2(3):250-254. [Content Brief]
- [5]. Limpitikul WB, et al. Calmodulin mutations associated with long QT syndrome prevent inactivation of cardiac L-type Ca(2+) currents and promote proarrhythmic behavior in ventricular myocytes. J Mol Cell Cardiol. 2014 Sep;74:115-24. [Content Brief]
- [6]. Pipilas DC, et al. Novel calmodulin mutations associated with congenital long QT syndrome affect calcium current in human cardiomyocytes. Heart Rhythm. 2016 Oct;13(10):2012-9. [Content Brief]
- [7]. Reed GJ, et al. CALM3 mutation associated with long QT syndrome. Heart Rhythm. 2015 Feb;12(2):419-22. [Content Brief]
- [8]. Boczek NJ, et al. Spectrum and Prevalence of CALM1-, CALM2-, and CALM3-Encoded Calmodulin Variants in Long QT Syndrome and Functional Characterization of a Novel Long QT Syndrome-Associated Calmodulin Missense Variant, E141G. Circ Cardiovasc Genet. 2016 Apr;9(2):136-146. [Content Brief]
- [9]. Christiansen SNN, et al. CALM1, CALM2, and CALM3 expression and translation efficiency provide insight into the severity of calmodulinopathy. Europace. 2026 Mar 30;28(4):euag052. [Content Brief]